InfuSystem Holdings, Inc. Share Price

Equities

INFU

US45685K1025

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:02 31/05/2024 BST 5-day change 1st Jan Change
7.14 USD +0.99% Intraday chart for InfuSystem Holdings, Inc. -0.14% -32.26%
Sales 2024 * 135M 10.63B Sales 2025 * 148M 11.61B Capitalization 152M 11.94B
Net income 2024 * 2M 157M Net income 2025 * 7M 549M EV / Sales 2024 * 1.12 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.03 x
P/E ratio 2024 *
63 x
P/E ratio 2025 *
20.2 x
Employees 508
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.92%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on InfuSystem Holdings, Inc.

1 day+0.99%
1 week-0.14%
1 month-8.23%
3 months-23.23%
6 months-29.31%
Current year-32.26%
More quotes
1 week
7.05
Extreme 7.05
7.55
1 month
6.25
Extreme 6.25
8.19
Current year
6.25
Extreme 6.25
10.58
1 year
6.25
Extreme 6.25
11.44
3 years
6.10
Extreme 6.1
21.89
5 years
4.20
Extreme 4.2
23.26
10 years
1.20
Extreme 1.2
23.26
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 31/12/03
President 47 31/12/09
Director of Finance/CFO 53 11/03/20
Members of the board TitleAgeSince
Director/Board Member 49 16/05/22
Chairman 58 06/09/16
Chief Executive Officer 49 31/12/03
More insiders
Date Price Change Volume
31/05/24 7.14 +0.99% 28,770
30/05/24 7.07 -3.68% 62,822
29/05/24 7.34 -2.26% 37,604
28/05/24 7.51 +5.03% 77,057
24/05/24 7.15 +3.32% 54,559

Delayed Quote Nyse, May 31, 2024 at 09:00 pm

More quotes
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.14 USD
Average target price
14.83 USD
Spread / Average Target
+107.75%
Consensus